Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
It further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.
Leading pharma companies i.e. Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are some of the marquee customers of Windlas Biotech. Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.
Funds from the fresh issue will be used for
The Company will utilize fresh issue proceeds to purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV. to finance incremental working capital requirements of the company. It will also be used for Repayment/prepayment of company's borrowings and for General corporate purposes
Company Financials: (in crores)
How to apply for an IPO/Buyback Online via Navjeevan?
Step 1: Go to our website and select an IPO that you wish to apply for.
Step 2: Log in your details (Non-Navjeevan Client can log in via their mobile number).
Step 2: Enter the price at which you want to apply for shares and the number of lots and provide your UPI ID
Step 4: Submit the application and then approve the block funds request on the UPI App.